Development of Gold-Bismuth Sulfide Nanorods (Au@Bi2S3 NRs) for X-ray- based imaging

The development of hybrid metal nanoparticles (NPs) for use as computed tomography (CT) contrast agents is a promising area of research. Achieving optimal in vivo performance of imaging for NPs is challenging and depends on their geometry, materials properties, bioreactivity, and biocompatibility. In this study, we designed and developed a novel CT contrast agent composed of gold nanoparticles (AuNPs) coordinated on the surface of bismuth sulfide-core nanorods (Au@Bi ₂ S ₃ NRs) utilizing a solvothermal synthesis approach. We conducted solid-state characterization of Au@Bi ₂ S ₃ NRs, demonstrating their structural configuration, excellent stability, uniformity, and high crystallinity. We also tested their biocompatibility with mesenchymal stem cells and found they exhibited no toxic effects. To evaluate the imaging potential of Au@Bi ₂ S ₃ NRs, we tested them in small animals using CT imaging. Our results showed contrast enhancement in soft tissues, indicating the retention of the particles at these locations with no local inflammatory responses. Taken together, our study provides a proof-of-concept for the robust synthesis and use of Au@Bi ₂ S ₃ NRs as effective CT imaging contrast agents. Future work will explore the potential to functionalize Au@Bi ₂ S ₃ NRs with therapeutic molecules for theranostic applications.